# Grace Therapeutics, Inc.: Form 8-K, filed Sep 22, 2021

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 8-K
- Filed: 2021-09-22
- Accepted by EDGAR: Sep 22, 2021, 08:30 ET
- Period: 2021-09-22
- Accession: 0001171843-21-006589
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000117184321006589/f8k_092221.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000117184321006589/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000117184321006589/f8k_092221.htm

Filed Sep 22, 2021.
Source: SEC EDGAR, the filing index for accession 0001171843-21-006589. Last ingested by Listed: Nov 12, 2026, 18:09 ET. No prices; not investment advice.
